HIGHLIGHTS
- who: August and colleagues from the Hospital of the Chinese People`s Liberation Army, China University, China have published the Article: Ef cacy of immune checkpoint inhibitors in EGFR-Mutant NSCLC patients with EGFR-TKI resistance: A systematic review and meta-analysis, in the Journal: (JOURNAL)
- what: The aim of this meta-analysis was to evaluate the efficacy of ICIs alone and in combination therapies in patients with advanced NSCLC resistant to EGFR-TKI, so as to better address the problems associated with the use of ICIs in such patients. Data synthesis and analysis Statistical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.